From Pricing To Patents: Hearing Signals A Potential New Focus

 
• By Jessica Merrill

Sen. Cornyn recommended the Judiciary Committee initiate an inquiry into drug patents after a back-and-forth with AbbVie CEO Gonzalez over the Humira patent estate at the drug pricing hearing.

NATIONAL HARBOR, MD - MARCH 7, 2014: Senator John Cornyn (R-TX) speaks at the Conservative Political Action Conference (CPAC). - Image

More from Legislation

More from Pink Sheet